International Journal of Hospital Pharmacy


Prevalence of Plasmodium Falciparum Malaria and the Antenatal Health Care Utilization for Prevention Among Pregnant Women in a Secondary Health Facility in Enugu State, Nigeria

Research Article of International Journal of Hospital Pharmacy Prevalence of Plasmodium Falciparum Malaria and the Antenatal Health Care Utilization for Prevention Among Pregnant Women in a Secondary Health Facility in Enugu State, Nigeria Maureen Ogochukwu Akunne*, Ebere Emilia Ayogu, Juliana Obianuju Idoko. Department of Clinical Pharmacy and Pharmacy Management, Faculty of Pharmaceutical Sciences, University of Nigeria, 410001 Nsukka, Enugu State, Nigeria Pregnant women in endemic areas are highly susceptible to malaria, and both the frequency and severity of the disease are higher in pregnant women than non- pregnant women.[1] In pregnancy, there is a transient depression of cell mediated immunity that allows foetal allograft retention but also interferes with resistance to various infectious diseases. Malaria infection during pregnancy is a major public health problem in the tropics and subtropics. It affects approximately 24 million pregnant women.[2] In the area of Africa with stable malaria transmission, plasmodium falciparum infection during pregnancy is estimated to cause as many as 10,000 maternal death each year, 8-14% of all low birth weight babies and 75,000-200,000 of all infant death.[3] In Nigeria, there is an estimated 25-30% of mortality in children under the age of five and 300,000 death each year due to malaria.[3] Studies have shown that 40% of pregnant African women start attending antenatal clinics in the first and second trimester of their pregnancy. [3] In addition, pregnant women are at immense risk of malaria due to natural immune depression in pregnancy. [4] The symptoms and complications of malaria during pregnancy differ with the intensity of malaria transmission and thus with the level of immunity the pregnant woman acquired. [5] Malaria cases and death have been increasing in the country mainly due to injudicious use of anti-malaria drugs, delayed health seeking and reliance on clinical judgment without laboratory confirmation in most of the ...

The New Era of Pharmacists in Ambulatory Patient Care

Review Article of International Journal of Hospital Pharmacy The New Era of Pharmacists in Ambulatory Patient Care AK Mohiuddin Department of Pharmacy, World University of Bangladesh, Bangladesh Pharmacy is evolving from a product-oriented to a patient-oriented profession. This role modification is extremely healthy for the patient, the pharmacist, and other members of the health-care team. However, the evolution will present pharmacists with a number of new challenges. Now, more than in the past, pharmacists must make the acquisition of contemporary practice knowledge and skills a high priority, to render the level of service embodied in the concept of pharmaceutical care. Pharmacy educators’ organizations and regulatory bodies must all work together to support pharmacists as they assume expanded health-care roles. Pharmacy and the health-care industry must work to ensure that the pharmacist is compensated justly for all services. But before this can happen it will be necessary for pharmacy to demonstrate value-added to the cost of the prescription. Marketing of the purpose of pharmacy in the health-care morass and of the services provided by the pharmacist is needed to generate an appropriate perceived value among purchasers and users of health-care services. Pharmacists should view themselves as dispensers of therapy and drug effect interpretations as well as of drugs themselves. Service components of pharmacy should be identified clearly to third party payers and be visible to consumers, so that they know what is available at what cost and how it may be accessed. In the future, pharmacy services must be evaluated on patient outcome (i.e., pharmaceutical care) rather than the number of prescriptions dispensed, and pharmacy must evolve toward interpretation and patient consultation, related to the use of medication technologies. Keywords: Community pharmacist; Provider; Medication; Outpatient; Care ...

Assessment of Drug Prescribing in Jordan Using World Health Organization Indicators

Research Article of International Journal of Hospital Pharmacy Assessment of Drug Prescribing in Jordan Using World Health Organization Indicators Alaa R.Alkhatib1, Anwar M. Batieha2, Nour M. Abdo3, Hayel M.Obeidat4, and Abdul Hakeem M. Okour5. 1.Jordan Food and Drug Administration, Shafa Badran, Amman, Jordan 11181 Jordan. 2.Professor of epidemiology and public health, Faculty of Medicine, Department of Public Health and Community Medicine,Jordan University of Science and Technology. 3.Assistant Professor of public health, Faculty of Medicine, Department of Public Health and Community Medicine, Jordan University of Science and Technology, 4.Director General of the Jordan Food and Drug Administration, ShafaBadran, Amman, Jordan 11181 Jordan.5.Associate Professor of maternal and child health, Faculty of Medicine, Department of Public Health and Community Medicine, Jordan University of Science and Technology. Background: Irrational drug use is a major public health problem worldwide. Patterns of prescribing of pharmaceuticals by physicians in Jordan have been scarcely studied. Objectives: To assess the drug prescribing patterns using World Health Organization Drug Use Indicators at 7 primary health care centers in Amman, the capital of Jordan. Methods: We prospectively evaluated 1055 prescriptions over a period of 2 months from May/2017 to July/2017, using the WHO prescribing indicators recommended protocol. Core prescribing indicators assessed in this study included the average number of drugs per prescription, the percentage of drugs prescribed by generic name, the percentage of prescriptions containing injections, the percentage of prescriptions containing antibiotics, and the percentage of drugs from the essential drugs list. Results: Our results showed that the average number of drugs per prescription was 3.0, the percentage of drugs written by generic name was 50.3%, the percentage of drugs written from essential drug list was 97.6%, and the percentages of prescriptions that contain injections and antibiotics were 7.1%, 61.0%, respectively. Conclusion: Three of the 5 indicators, namely, the average number ...

Pharmacovigilance and Managing ADRS in Bangladesh: Eccentric or Non-existent?

Research Article of International Journal of Hospital Pharmacy Pharmacovigilance and Managing ADRS in Bangladesh: Eccentric or Non-existent? AK Mohiuddin Department of Pharmacy, World University of Bangladesh, Bangladesh 151/8, Green Road Dhanmondi, Dhaka 1205, Bangladesh Bangladesh became the 120th member of the WHO’s International Drug Monitoring Center (WHO-UMC). Through this membership, Bangladesh has gained international recognition and access to early worldwide information about potential safety risks. It was introduced in Bangladesh in 1999. However, due to a shortage of manpower and a lack of financial support, the program became dormant. It was revived in 2013 when the DGDA established the ADR Monitoring cell. Major advancements of the discipline of pharmacovigilance have taken place in the West, still, not much has been achieved in Bangladesh. The article highlights the various serious incidences ADRs, present health situation and broader scope of pharmacovigilance in Bangladesh. Keywords: National Drug Policy (NDP), The Directorate General of Drug Administration (DGDA), Drug Control Ordinance, Essential Medicine List (EML), Standard Treatment Guidelines (STG) ...


Editor-in-chief: 
Dr. Fadi Alkhateeb 
Associate Dean of Academic Affairs and Associate Professor, Ben and Maytee Fisch College of Pharmacy, The University of Texas at Tyler, 3900 University Blvd, Office # 328, Tyler, TX 75799

Vice Editor-in-Chief:
Dr. Saurabh Gupta 
Professor and Head, Department of Pharmacology, Indore Institute of Pharmacy, Indore (M.P.), India; Principal Co-ordinator Scientist for outsources projects of industry, Indore institute of Pharmacy, Indore (M.P.), India,; Scientist Co-ordinator member of Institutional Animal Ethical Committee, Indore institute of Pharmacy, Indore.

Editors

Dr. Mohammed A. Islam
Department of Pharmaceutical Sciences, West Coast University School of Pharmacy, Los Angeles, CA, USA.

Dr. Juseop Kang
Department of Pharmacology and Clinical Pharmacology Laboratory, College of Medicine, Hanyang University, Seoul 133-791, South Korea.

Dr. Mohamed Azmi Hassali
Professor of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia.

Dr. Apollo James
Department of Pharmacy Practice, Nandha college of Pharmacy, Erode, Tamilnadu, India.

Dr. Iftikhar Ali
Department of Pharmacy, Northwest General Hospital and Research Center, Department of Pharmacy, University of Swabi, Khyber Pakhtunkhwa , Pakistan.

Dr Anthony David Hall
School of Clinical Sciences, Queensland University of Technology (QUT), Brisbane, Australia.

Dr Bhanukumar M
Department of General Medicine, JSS Hospital & Medical College, JSS University, Mysore, India.

Dr. Sandeep Kumar Kar
Institute of Postgraduate Medical Education & Research, India.

Dr. Biswaranjan Paital
Department of Zoology, Orissa University of Agriculture and Technology, College of Basic Science and Humanities, Bhubaneswar-751003, Odisha, India.

Dr. Vasiliki E. Kalodimou
Director at Flow Cytometry-Research & Regenerative Medicine Department, Athens, Greece.

Dr. Hale Z. Toklu
Department of Pharmacology & Therapeutics, University of Florida College of Medicine, 32610 Gainesville, FL, USA.

Dr. Fahad Saleem
Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains, Malaysia, Minden 11800, Penang, Malaysia

Dr. Ahamada Safna Mariyam.M
Dept of Pharmacy Practice, Acharya & B.M Reddy College of Pharmacy, Bangalore-107, India.

Dr. Ghada Ismail El Shahat Ali Attia
Literature of Pharmacognosy, Departments of Pharmacognosy, Faculty of Pharmacy, TANTA University- Egypt

Dr. Tauqeer Hussain Mallhi
School Of Pharmaceutical Sciences, Usm, Penang, Malaysia

Dr. Burton M. Altura

Physiology and Pharmacology Department, SUNY Downstate Medical Center, NY, USA.

Dr.  Yousif Abdu Asiri
Vice – Rector for Planning and Development, Professor of Clinical Pharmacy, King Saud University,, Riyadh 11451, Saudi Arabia.

Dr. Amit K. Tiwari
Department of Pharmacology & Experimental Therapeutics, The University of Toledo – Health Science Campus, Toledo, OH, USA.

Dr. Saurabh Gupta
Professor and Head, Department of Pharmacology, Indore Institute of Pharmacy, Indore (M.P.), India, Principal Co-ordinator Scientist for outsources projects of industry, Indore institute of Pharmacy, Indore (M.P.), India, Scientist Co-ordinator member of Institutional Animal Ethical Committee, Indore institute of Pharmacy, Indore.

Dr. Tyler Madere
University of North Texas System College of Pharmacy –Department of Pharmacotherapy, Fort Worth, TX,USA.

Dr. Xianquan Zhan
Professor and Deputy Director, Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China

Dr. Fatima Suleman
Head of Discipline of Pharmaceutical Sciences, School of Health Sciences, College of Health Sciences of University of KwaZulu-Natal, Durban, South Africa.

Dr. Mohamed Eddouks
Faculty of Sciences and Techniques Errachidia, Moulay Ismail University, Meknes, Morocco.

Dr.  Syed A. A. Rizvi 
Department of Pharmaceutical Sciences, College of Pharmacy, Health Professions Division, Nova Southeastern University, FL, USA.

Dr. Carmela Saturnino 
Faculty of Pharmacy, University of Salerno, SA, ITALY.

Dr. Taha Nazir
University of Sargodha, Sargodha 40100, Pakistan.

Dr. Fadi Alkhateeb
Pharmacy Administration, Department of Pharmacy Practice, Irma Lerma Rangel College of Pharmacy, Texas A&M Health Science Center, Kingsville, Texas, USA.

Dr. Madhan Ramesh
Professor & Head, Department of Pharmacy Practice, JSS College of Pharmacy, JSS University, S S Nagar, Mysore.

Sushanta Kr. Das.
M. Pharm (Pharmacy Practice), Associate Professor and Pharm D Coordinator, CMR College of Pharmacy, Hyderabad

Dr. Mario Bernardo-Filho
Professor Titular, Universidade do Estado do Rio de Janeiro

Manuscript Title: The title should be a brief phrase.

Author Information: List full names and affiliation of all authors, including Emails and phone numbers of corresponding author.

Abstract: The abstract should be less than 500 words. Following abstract, a list of keywords and abbreviations should be added. The keywords should be no more than 10. Abbreviation are only used for non standard and long terms.

Introduction: The introduction should included a clear statement of current problems.

Materials and Methods: This section should be clearly described.

Results and discussion: Authors may put results and discussion into a single section or show them separately.

Acknowledgement: This section includes a brief acknowledgment of people, grant details, funds

References: References should be listed in a numbered citation order at the end of the manuscript. DOIs and links to referenced articles should be added if available. Abstracts and talks for conferences or papers not yet accepted should not be cited. Examples Published Papers: 

1.Kim P.G.M. Hurkens, Carlota Mestres-Gonzalvo, Hugo A.J.M. de Wit, Rob Janknegt, Frans Verhey, Jos M.G.A. Schols, Fabienne Magdelijns, Coen D.A. Stehouwer, Bjorn Winkens, Wubbo Mulder and P. Hugo M. van der Kuy. Assessing the strengths and weaknesses of a computer assisted medication review in hospitalized patients. International Journal of Hospital Pharmacy, 2017,2:6. DOI: 10.28933/IJHP-2017-10-0101 
2.Ananth kashyap, Rashmi N G, Rakshith U R, Hanumanthachar Joshi.Selective Serotonin Reuptake Inhibitors Induced Serotonin Syndrome –A Case Report. International Journal of Hospital Pharmacy, 2017,2:7. DOI:10.28933/ijhp-2017-10-1101

Tables and figures: Tables should be used at a minimum with a short descriptive title. The preferred file formats for Figures/Graphics are GIF, TIFF, JPEG or PowerPoint.

Proofreading and Publication: A proof will be sent to the corresponding author before publication. Authors should carefully read the proof to avoid any errors and return the proof to the editorial office. Editorial office will publish the article shortly and send a notice to authors with the links of the paper.

Open Access
International Journal of Hospital Pharmacy is a peer reviewed open access journal publishing research manuscripts, review articles, case reports, editorials, letters to the editor in Hospital Pharmacy (indexing details).

Peer Review
To ensure the quality of the publications, all submitted manuscripts will be peer-reviewed by invited experts in the field. The decisions of editors will be made based on the comments of the reviewers.

Rapid Publication
Time to first decision: within 2 days for initial decision without review, 18 days with review; Time to publication: Accepted articles will be published online within 2 days, and final corrected versions by authors will be accessible within 5 days. More details....

Rapid Response Team
Please feel free to contact our rapid response team if you have any questions. Our customer representative will answer you shortly.

International Journal of Hospital Pharmacy

Loading